Back to Search
MICHAEL ORLANDO, DMD
DMD
Dentist
NPI: 1174557870Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer.
PMID 10761752·Ann Oncol·2000
4-observational
Pressure study of monoclinic ReO2 up to 1.2 GPa using X-ray absorption spectroscopy and X-ray diffraction.
PMID 19096174·J Synchrotron Radiat·2009
8-other
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
PMID 18829514·Clin Cancer Res·2008
3-trial
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium.
PMID 18096563·Hum Reprod·2008
8-other
Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.
PMID 17960360·Diabetologia·2008
8-other
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer.
PMID 17588704·Lung Cancer·2007
3-trial
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
PMID 17602086·J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1845 HOLSONBACK DR
DAYTONA BEACH, FL 32117 - Phone
- (386) 274-0790
Quick Facts
- NPI
- 1174557870
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile